Gene therapy shows promise for HIV patients battling cancer
NCT ID NCT03593187
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This early-stage study tested a new gene therapy in 2 HIV patients who also had a high-risk lymphoma. The goal was to see if it's safe to add a special anti-HIV gene to their blood stem cells and immune cells before a stem cell transplant. The approach aims to help control HIV while treating the lymphoma, but patients may still need ongoing HIV medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Saint Louis
Paris, 75475, France
Conditions
Explore the condition pages connected to this study.